Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
ADCs
Biotech
Mersana's phase 1 ADC cancer trial breaks free of FDA hold
The FDA has lifted a clinical hold on Mersana Therapeutics' phase 1 trial assessing ADC XMT-2056.
Gabrielle Masson
Oct 31, 2023 1:21pm
ESMO: AstraZeneca's '2.0' cancer pipeline built on bispecifics
Oct 24, 2023 10:36am
GSK pays $85M cash for China biotech's ADC
Oct 20, 2023 1:19pm
Byondis breast cancer drug fails to bloom as FDA denies approval
May 16, 2023 8:28pm
Drug-resistant lung cancer curbed with CD70-targeted therapies
Feb 16, 2023 2:14pm